Ivermectin in rosacea

NICE has issued advice on the use of ivermectin cream for inflammatory lesions in papulopustular rosacea

In two RCTs, ivermectin 10mg/g cream was statistically significantly more effective than vehicle cream (placebo) in improving rosacea severity score and reducing inflammatory lesion count. 

In another RCT, ivermectin was superior to metronidazole cream at reducing lesion count and improving rosacea severity score, with study participants having about 10% fewer lesions. Local adverse events, including skin irritation, pruritus and dry skin, are common, although these are mostly transient, and mild to moderate in severity. 

More than two-thirds of patients using ivermectin rated their improvement as ‘excellent’ or ‘good’, compared with about one-third of people in the vehicle group.

ESNM68. London, NICE, January 2016

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.